A Teva Pharmaceutical Industries Ltd. (TEVA) unit and two other drugmakers were ordered by a jury to pay at least $20.1 million for selling the anesthetic Propofol in a way that led three colonoscopy patients to develop Hepatitis C. Jurors in state court in Las Vegas deliberated a total of seven hours yesterday before finding Teva Parenteral Medicines Inc., Baxter Healthcare Corp. and McKesson Corp. wrongfully sold Propofol in vials large enough to be used on multiple patients. Anne Arnold, Richard Sacks and Anthony Devito contend they contracted Hepatitis C from reused vials during colonoscopy procedures.
